Victory Capital Management
DALS

Victory Capital Management’s DA32 Life Science Tech Acquisition Corp. Class A Common Stock DALS Stock Holding History

Victory Capital Management’s Portfolio DALS Stock Details DALS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-227,345
Closed -$2.2M – 2749
2022
Q3 		$2.2M Sell
227,345
-8,580
-4% -$83.4K ﹤0.01% 1424
2022
Q2 		$2.29M Hold
235,925
– – ﹤0.01% 1428
2022
Q1 		$2.3M Sell
235,925
-3,960
-2% -$38.2K ﹤0.01% 1451
2021
Q4 		$2.35M Sell
239,885
-15,645
-6% -$153K ﹤0.01% 1505
2021
Q3 		$2.51M Buy
+255,530
New +$2.53M ﹤0.01% 1527

Other funds holding DALS

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Saba Capital Management New York $3.62B AUM 13% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
CIM
Cowen Investment Management New York $12M AUM 1.47% 1-Year Est. Return
SC
Sculptor Capital New York $9.61B AUM 27.49% 1-Year Est. Return
MCM
Moore Capital Management New York $4.92B AUM 35.41% 1-Year Est. Return

Victory Capital Management's DALS Position: Q4 2022 in Review

Victory Capital Management sold out of DA32 Life Science Tech Acquisition Corp. Class A Common Stock (DALS) in Q4 2022, closing a stake of 227,345 shares — an estimated $2.2M sold.

Victory Capital Management first reported a position in DALS in Q3 2021 and held it in 5 quarters. The position peaked at $2.51M in Q3 2021. 47 funds tracked by Wall St. Rank hold DALS as of Q4 2022.

  • Victory Capital Management reported no remaining DA32 Life Science Tech Acquisition Corp. Class A Common Stock position as of Q4 2022 after selling out during the quarter.
  • Victory Capital Management sold 227,345 DA32 Life Science Tech Acquisition Corp. Class A Common Stock shares in Q4 2022, an estimated $2.2M.
  • Victory Capital Management first reported a position in DA32 Life Science Tech Acquisition Corp. Class A Common Stock in Q3 2021 and held it in 5 quarters.
  • Victory Capital Management's DA32 Life Science Tech Acquisition Corp. Class A Common Stock position peaked at $2.51M in Q3 2021.
  • 47 funds tracked by Wall St. Rank held DA32 Life Science Tech Acquisition Corp. Class A Common Stock as of Q4 2022.

Based on Victory Capital Management's 13F filing for Q4 2022, filed 9 Feb 2023.